𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunologic impairment in patients with non-lymphoid cancer. Correlation with the tumoral stage, response to treatment, and survival

✍ Scribed by E. Simó-Camps; A. Anguera; J. Ma Vich; A. Vidal-Ribas; F. Sala; R. Sarrias; J. Gumma; E. Gri; J. Ma Puigdollers

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
397 KB
Volume
37
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum CA 125 is of clinical value in the
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity
✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma : Correlation with tumor parameters and disease activity
✍ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen

Treatment, patterns of failure, and surv
Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the comprehensive cancer centre west
✍ Augustinus D. Krol; Jo Hermans; Lilian Dawson; Simone Snijder; Pierre W. Wijerma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## BACKGROUND. Primary extranodal lymphomas (EN-NHLs) are a heterogeneous category of tumors that are considered to be different from primary nodal non-Hodgkin's lymphomas (N-NHLs). To what extent these differences have clinical implications is currently not very clear, because knowledge of EN-NHL